Alpha 2.0
Login Register
» Articles » PMID: 2505304

Fluvoxamine, Imipramine, and Placebo in the Treatment of Depressed Outpatients: Effects on Depression

Overview
Journal Psychopharmacol Bull
Specialty Pharmacology
Date 1989 Jan 1
PMID 2505304
Citations 11
Authors
R B Lydiard
L K Laird
W A MORTON Jr
T E Steele
C Kellner
M T Laraia
J C Ballenger
Affiliations
Soon will be listed here.
Citing Articles

Beneficial and harmful effects of tricyclic antidepressants for adults with major depressive disorder: a systematic review with meta-analysis and trial sequential analysis.

Kamp C, Petersen J, Faltermeier P, Juul S, Siddiqui F, Barbateskovic M BMJ Ment Health. 2024; 27(1.

PMID: 39093721 PMC: 10806869. DOI: 10.1136/bmjment-2023-300730.

Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis.

Jakobsen J, Katakam K, Schou A, Hellmuth S, Stallknecht S, Leth-Moller K BMC Psychiatry. 2017; 17(1):58.

PMID: 28178949 PMC: 5299662. DOI: 10.1186/s12888-016-1173-2.

Systematic Review and Meta-Analysis: Dose-Response Relationship of Selective Serotonin Reuptake Inhibitors in Major Depressive Disorder.

Jakubovski E, Varigonda A, Freemantle N, Taylor M, Bloch M Am J Psychiatry. 2015; 173(2):174-83.

PMID: 26552940 PMC: 4975858. DOI: 10.1176/appi.ajp.2015.15030331.

Comparative efficacy and risk of harms of immediate- versus extended-release second-generation antidepressants: a systematic review with network meta-analysis.

Nussbaumer B, Morgan L, Reichenpfader U, Greenblatt A, Hansen R, Van Noord M CNS Drugs. 2014; 28(8):699-712.

PMID: 24794101 DOI: 10.1007/s40263-014-0169-z.

The relationship between borderline personality disorder and bipolar disorder.

Zimmerman M, Morgan T Dialogues Clin Neurosci. 2013; 15(2):155-69.

PMID: 24174890 PMC: 3811087.